arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

DAVITA INC.

DVA
$194.70 ▲ +2.04 (+1.06%) at close
Healthcare ·Services-Misc Health & Allied Services, NEC ·USServices-Misc Health & Allied Services, NEC
20 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
48
Health
Weak
Bearish
auto_awesome

Analytical Summary

DAVITA INC. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $14.5B
Dividend Yield —
Revenue Growth 6.5% ↗
Op. Margin 15.0% ↘
ROIC -245.6% ↘
FCF / Share $17.66 ↗
Trailing P/E 19.4x
Price / Book —
FCF Yield 9.1%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$13.64B
↑ +6.5% —
Net Income Profit after all expenses
$746.80M
↓ -20.2% —
Operating Margin Operating profit as % of sales
15.0%
↓ -8.2% 67th
FCF / Share Free cash flow per share
$17.66
↑ +2.3% —
Long-Term Debt Long-term obligations
$8.50B
↑ +1.0% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
60
Returns
7
Financial Health ↓
69
Cash Quality ↑
83

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 20 years · 76 quarters